rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
1999-2-25
|
pubmed:abstractText |
The purpose of this study was to investigate the in vivo pharmacodynamics and the pharmacodynamic interactions of remifentanil and its major metabolite, GR90291, in a rat electroencephalographic model.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0003-3022
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
90
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
535-44
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9952162-Analgesics, Opioid,
pubmed-meshheading:9952162-Anesthetics, Intravenous,
pubmed-meshheading:9952162-Animals,
pubmed-meshheading:9952162-Brain,
pubmed-meshheading:9952162-Drug Interactions,
pubmed-meshheading:9952162-Infusions, Intravenous,
pubmed-meshheading:9952162-Male,
pubmed-meshheading:9952162-Piperidines,
pubmed-meshheading:9952162-Rats,
pubmed-meshheading:9952162-Rats, Wistar
|
pubmed:year |
1999
|
pubmed:articleTitle |
The comparative pharmacodynamics of remifentanil and its metabolite, GR90291, in a rat electroencephalographic model.
|
pubmed:affiliation |
Division of Pharmacology, Leiden/Amsterdam Center for Drug Research, Leiden University, The Netherlands.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|